G. Hillman

G. Haas, B. Redman, J. Pontes, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

INTERLEUKIN-13 RECEPTORS ON HUMAN PROSTATE CARCINOMA CELL LINES REPRESENT A NOVEL TARGET FOR A CHIMERIC PSEUDOMONAS EXOTOXIN PROTEIN COMPOSED OF IL-13 AND A MUTATED FORM OF

I. Pastan, G. Haas, R. Puri, 1997 .

Experimental animal models for the study of therapeutic approaches in renal cell carcinoma.

G. Haas, J. Droz, G. Hillman, 1994, In vivo.

Forcing tumor cells to present their own tumor antigens to the immune system: a necessary design for an efficient tumor immunotherapy.

E. von Hofe, Minzhen Xu, R. Humphreys, 2004, Cellular & molecular immunology.

Radiation improves intratumoral gene therapy for induction of cancer vaccine in murine prostate carcinoma.

Jennifer L. Wright, J. Forman, T. Thompson, 2003, Human gene therapy.

Radioprotection of Lung Tissue by Soy Isoflavones

F. Sarkar, S. Gadgeel, C. K. Yunker, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Turning tumor cells in situ into T-helper cell-stimulating, MHC class II tumor epitope-presenters: immuno-curing and immuno-consolidation.

Jennifer L. Wright, Y. Li, J. Forman, 2004, Cancer treatment reviews.

Dietary Agents in Cancer Chemoprevention and Treatment

F. Sarkar, O. Kucuk, G. Hillman, 2012, Journal of oncology.

Daidzein Effect on Hormone Refractory Prostate Cancer In Vitro and In Vivo Compared to Genistein and Soy Extract: Potentiation of Radiotherapy

H. Zhang, F. Sarkar, Christopher K. Yunker, 2010, Pharmaceutical Research.

Attenuation of multi-targeted proliferation-linked signaling by 3,3'-diindolylmethane (DIM): from bench to clinic.

B. Bao, Zhiwei Wang, Sanjeev Banerjee, 2011, Mutation research.

Soy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and Neutrophils

J. Rakowski, M. Joiner, Christopher K. Yunker, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Experimental Animal Models for Investigating Renal Cell Carcinoma Pathogenesis and Preclinical Therapeutic Approaches

G. Hillman, 2011 .

Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii protein.

J. Forman, Yu Wang, E. von Hofe, 2005, Human gene therapy.

Tumor immunotherapy by converting tumor cells to MHC class II–positive, Ii protein–negative phenotype

Y. Li, Zhong Jiang, N. Kallinteris, 2003, Cancer Immunology, Immunotherapy.

DNA Repair and Cancer Therapy: Targeting APE1/Ref-1 Using Dietary Agents

A. Heydari, G. Hillman, J. J. Raffoul, 2012, Journal of oncology.

51Cr-release assay adapted to a 96-well format sample reading.

G. Haas, J. Pontes, G. Hillman, 1993, BioTechniques.

Soy Isoflavones in Conjunction With Radiation Therapy in Patients With Prostate Cancer

F. Sarkar, J. Forman, E. Heath, 2010, Nutrition and cancer.

Prostate Cancer Treatment is Enhanced by Genistein In Vitro and In Vivo in a Syngeneic Orthotopic Tumor Model

F. Sarkar, O. Kucuk, Yu Wang, 2006, Radiation research.

Radiation‐induced HIF‐1α cell survival pathway is inhibited by soy isoflavones in prostate cancer cells

H. Zhang, Sanjeev Banerjee, D. Kong, 2009, International journal of cancer.

Isoflavone-mediated radioprotection involves regulation of early endothelial cell death and inflammatory signaling in Radiation-Induced lung injury

Laura A. McLellan, J. Rakowski, H. Tse, 2020, International journal of radiation biology.

Generating MHC Class II+/Ii- phenotype after adenoviral delivery of both an expressible gene for MHC Class II inducer and an antisense Ii-RNA construct in tumor cells

Jennifer L. Wright, J. Wright, S. Wu, 2003, Gene Therapy.

Soy Isoflavones Protect Normal Tissues While Enhancing Radiation Responses.

G. Hillman, 2019, Seminars in radiation oncology.

Radiation injury to cardiac arteries and myocardium is reduced by soy isoflavones

M. Dominello, M. Joiner, G. Hillman, 2017, Journal of Radiation Oncology.

Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin.

I. Pastan, G. Haas, R. Puri, 1997, The Journal of urology.

Immunotherapy for lung metastases of murine renal cell carcinoma: synergy between radiation and cytokine-producing tumor vaccines.

G. Haas, G. Hillman, A. Maini, 1999, Journal of immunotherapy.

Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model.

D. Grignon, M. Cher, J. Pontes, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prospects of immunotherapy for the treatment of prostate carcinoma--a review.

M. Cher, G. Hillman, J. Triest, 1999, Cancer detection and prevention.

Application of the direct beta counter Matrix 96 for cytotoxic assays: Simultaneous processing and reading of 96 wells using a51Cr-retention assay

G. Haas, J. Pontes, G. Hillman, 1993, Cancer Immunology, Immunotherapy.

Responsiveness of human prostate carcinoma bone tumors to interleukin-2 therapy in a mouse xenograft tumor model.

D. Grignon, J. Pontes, G. Hillman, 1999, Cancer detection and prevention.

Development of immunotherapy for the treatment of malignancies refractory to conventional therapies.

G. Haas, G. Hillman, S. Kim, 1996, Cytokines and molecular therapy.

Genistein inhibits radiation-induced activation of NF-κB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest

F. Sarkar, J. Forman, O. Kucuk, 2006, BMC Cancer.

Radiation therapy enhances the therapeutic effect of immunotherapy on pulmonary metastases in a murine renal adenocarcinoma model.

G. Haas, J. Pontes, G. Hillman, 1994, In Vivo.

Soy isoflavones sensitize cancer cells to radiotherapy.

G. Hillman, V. Singh-Gupta, 2011, Free radical biology & medicine.

Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model.

F. Sarkar, J. Forman, B. Marples, 2004, Molecular cancer therapeutics.

Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model

Sanjeev Banerjee, F. Sarkar, J. Abrams, 2007, International journal of cancer.

Soy Isoflavones Augment Radiation Effect by Inhibiting APE1/Ref-1 DNA Repair Activity in Non-small Cell Lung Cancer

F. Sarkar, S. Gadgeel, M. Joiner, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.

H. Zhang, Sanjeev Banerjee, F. Sarkar, 2007, Cancer research.

Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model

F. Sarkar, O. Kucuk, Yu Wang, 2007, BMC Cancer.

Axitinib Improves Radiotherapy in Murine Xenograft Lung Tumors

S. Gadgeel, J. Rakowski, M. Joiner, 2014, Translational oncology.

Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma.

F. Sarkar, S. Gadgeel, J. Rakowski, 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase

D. Grignon, D. Nie, K. Honn, 2004, Clinical & Experimental Metastasis.

Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors.

Areen K. Al-Bashir, E. Haacke, Meng Li, 2009, Neoplasia.

Genistein potentiates the radiation effect on prostate carcinoma cells.

F. Sarkar, J. Forman, J. Abrams, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.

James J. Evans, W. Curran, K. Camphausen, 2014, International journal of radiation oncology, biology, physics.

Expansion of Activated Lymphocytes Obtained from Renal Cell Carcinoma in an Automated Hollow Fiber Bioreactor

G. Haas, J. Pontes, G P Haas, 1994, Cell transplantation.

Neutron or photon irradiation for prostate tumors: enhancement of cytokine therapy in a metastatic tumor model.

D. Grignon, M. Yudelev, G. Hillman, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Immunotherapy of cancer by antisense inhibition of Ii protein, an immunoregulator of antigen selection by MHC class II molecules.

E. von Hofe, N. Kallinteris, J. Gulfo, 2004, Current opinion in molecular therapeutics.

Monitoring sunitinib-induced vascular effects to optimize radiotherapy combined with soy isoflavones in murine xenograft tumor.

Areen K. Al-Bashir, F. Sarkar, E. Haacke, 2011, Translational oncology.

Influence of tumor site on the therapy of murine kidney cancer.

G. Haas, D. Visscher, J. Pontes, 1994, Anticancer Research.

B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer.

Sanjeev Banerjee, F. Sarkar, J. Rakowski, 2012, Cancer letters.

Soy isoflavones radiosensitize lung cancer while mitigating normal tissue injury.

F. Sarkar, S. Gadgeel, S. Sethi, 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dynamic contrast-enhanced magnetic resonance imaging of sunitinib-induced vascular changes to schedule chemotherapy in renal cell carcinoma xenograft tumors.

Areen K. Al-Bashir, H. Zhang, E. Haacke, 2010, Translational oncology.

Responsiveness of experimental prostate carcinoma bone tumors to neutron or photon radiation combined with cytokine therapy.

Jennifer L. Wright, D. Grignon, J. Forman, 2003, International journal of radiation oncology, biology, physics.

Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Vascular Changes Induced by Sunitinib in Papillary Renal Cell Carcinoma Xenograft Tumors 1

Areen K. Al-Bashir, E. Haacke, Meng Li, 2014 .

Soy Isoflavones in Conjunction With Radiation Therapy in Patients With Prostate Cancer

F. Sarkar, J. Forman, E. Heath, 2010, Nutrition and cancer.

Radiosensitization of prostate cancer by soy isoflavones.

F. Sarkar, G. Hillman, J. J. Raffoul, 2007, Current cancer drug targets.

New DCE-MRI parameters to quantify the vascular changes induced by sunitinib treatment in renal carcinoma tumors

Areen K. Al-Bashir, E. Haacke, M. Li, 2014, 2nd Middle East Conference on Biomedical Engineering.